Free Trial
TSE:FRX

Fennec Pharmaceuticals (FRX) Stock Price, News & Analysis

Fennec Pharmaceuticals logo
C$11.67 -0.25 (-2.10%)
As of 01:10 PM Eastern

About Fennec Pharmaceuticals Stock (TSE:FRX)

Key Stats

Today's Range
C$11.67
C$11.67
50-Day Range
C$8.55
C$12.50
52-Week Range
C$5.65
C$12.99
Volume
100 shs
Average Volume
1,113 shs
Market Capitalization
C$225.05 million
P/E Ratio
N/A
Dividend Yield
2.02%
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Receive FRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

FRX Stock News Headlines

Fennec Pharmaceuticals Inc. (FENC) - Yahoo Finance
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Fennec reports Q4 EPS (6c), consensus (13c)
Fennec Pharmaceuticals (FENC) Gets a Buy from Craig-Hallum
See More Headlines

FRX Stock Analysis - Frequently Asked Questions

Fennec Pharmaceuticals' stock was trading at C$8.87 at the start of the year. Since then, FRX stock has increased by 31.6% and is now trading at C$11.67.

Fennec Pharmaceuticals Inc. (TSE:FRX) issued its quarterly earnings results on Thursday, November, 7th. The biopharmaceutical company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by $0.10. Fennec Pharmaceuticals had a positive trailing twelve-month return on equity of 29.94% and a negative net margin of 2.30%.

Shares of FRX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fennec Pharmaceuticals investors own include Tilray Brands (TLRY), Aurora Cannabis (ACB), Encanto Potash (EPO), Adherex Technologies (FENC), Ocugen (OCGN), Passport Potash (PPI) and Workhorse Group (WKHS).

Company Calendar

Last Earnings
11/07/2024
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:FRX
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
19.33
P/E Growth
N/A
Net Income
-C$800.44 thousand
Net Margins
-2.30%
Pretax Margin
N/A
Return on Equity
29.94%
Return on Assets
8.88%

Debt

Debt-to-Equity Ratio
-620.83
Current Ratio
7.80
Quick Ratio
10.17

Sales & Book Value

Annual Sales
C$34.86 million
Price / Sales
6.46
Cash Flow
C$1.00 per share
Price / Cash Flow
11.66
Book Value
C($0.19) per share
Price / Book
-61.60

Miscellaneous

Outstanding Shares
19,284,690
Free Float
N/A
Market Cap
C$225.05 million
Optionable
Not Optionable
Beta
0.25
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (TSE:FRX) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners